Literature DB >> 19870257

A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

R C Lancefield1.   

Abstract

Under uniform diet conditions the normal bile fistula dog will eliminate pretty constant amounts of cholesterol-about 0.5 to 1.0 mg. cholesterol per kilo per 24 hours. Diets rich in cholesterol (egg yolk) will raise the cholesterol output in the bile but compared to the diet intake (1.5 gm. cholesterol) the output increase in the bile is trivial (5-15 mg.). Calves' brains in the diet are inert. Bile salt alone will raise the cholesterol output in the bile as much and often more than a cholesterol rich diet. Bile salt plus egg yolk plus whole bile give maximal output figures for bile cholesterol-60 mg. per 24 hours. Liver injury (chloroform) decreases both bile salt and cholesterol elimination in the bile. Blood destruction (hydrazine) fails to increase the bile cholesterol output and this eliminates the red cell stroma as an important contributing factor. Certain cholagogues (isatin and decholin) will increase the bile flow but cause no change in cholesterol elimination. The ratio of cholesterol to bile salt in the bile normally is about 1 to 100 but the bile salts are more labile in their fluctuations. The ratio is about reversed in the circulating blood plasma where the cholesterol is high (150-300 mg. per cent) and the bile salt concentration very low. Cholesterol runs so closely parallel to bile salt in the bile that one may feel confident of a physical relationship. In addition there is a suspicion that the bile cholesterol is in some obscure fashion linked with the physiological activity of hepatic epithelium.

Entities:  

Year:  1934        PMID: 19870257      PMCID: PMC2132330          DOI: 10.1084/jem.59.4.441

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  A R Dochez; O T Avery; R C Lancefield
Journal:  J Exp Med       Date:  1919-09-01       Impact factor: 14.307

2.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : V. ANAPHYLAXIS WITH THE TYPE-SPECIFIC SUBSTANCE.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-05-31       Impact factor: 14.307

3.  STUDIES ON THE RELATIONSHIP OF STREPTOCOCCUS HEMOLYTICUS TO THE RHEUMATIC PROCESS : II. OBSERVATIONS ON THE BIOLOGICAL CHARACTER OF STREPTOCOCCUS HEMOLYTICUS ASSOCIATED WITH RHEUMATIC DISEASE.

Authors:  A F Coburn; R H Pauli
Journal:  J Exp Med       Date:  1932-10-31       Impact factor: 14.307

4.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : III. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE SPECIES-SPECIFIC SUBSTANCE.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-02-29       Impact factor: 14.307

5.  A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

  5 in total
  74 in total

1.  False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.

Authors:  H-C Slotved; S Sauer; H B Konradsen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Emergence of invasive serotype VIII group B streptococcal infections in Denmark.

Authors:  Kim Ekelund; Hans-Christian Slotved; Hans Ulrik Nielsen; Margit S Kaltoft; Helle B Konradsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

3.  [Production of group-specific sera for differentiation of streptococci].

Authors:  M SEELEMANN; G OBIGER
Journal:  Z Hyg Infektionskr       Date:  1958

4.  Increased sensitivity of a latex agglutination method for serotyping group B streptococcus.

Authors:  John A Elliott; Terry A Thompson; Richard R Facklam; Hans-Christian Slotved
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

5.  [Not Available].

Authors:  G B ROEMER
Journal:  Klin Wochenschr       Date:  1948-08-01

6.  Identification of Streptococcus pyogenes - Phenotypic Tests vs Molecular Assay (spy1258PCR): A Comparative Study.

Authors:  Tintu Abraham; Sujatha Sistla
Journal:  J Clin Diagn Res       Date:  2016-07-01

7.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Biographical Feature: Rebecca Lancefield, Ph.D.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

9.  Novel observation of hot-cold-hot hemolysis exhibited by group B streptococci.

Authors:  Norio Okazaki; Ro Osawa; Rieko Suzuki; Takayasu Nikkawa; Robert A Whiley
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease.

Authors:  Pia S Pannaraj; Joanna K Kelly; Marcia A Rench; Lawrence C Madoff; Morven S Edwards; Carol J Baker
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.